ICOS and Autoimmunity: Indeed, patients with ICI-T1DM had a more robust Tfh cell response than those without IrAEs, with increased CD4+ICOS+PD-1hiCXCR5+ cells compared with controls without autoimmunity (Figure 1B; P < 0.05).